Carter to lead Fusion Energy Division at Oak Ridge National Laboratory
Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Nuclear Science and Technology (4)
- (-) Supercomputing (17)
- Biology and Environment (6)
- Clean Energy (39)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (1)
- Energy Frontier Research Centers (1)
- Fusion and Fission (2)
- Isotopes (11)
- Materials (32)
- Materials for Computing (5)
- Mathematics (1)
- National Security (6)
- Neutron Science (7)
- Quantum information Science (2)
- Sensors and Controls (1)
News Topics
- (-) Climate Change (3)
- (-) Cybersecurity (4)
- (-) Energy Storage (3)
- (-) Frontier (5)
- (-) Isotopes (2)
- (-) Nanotechnology (2)
- (-) Security (2)
- (-) Space Exploration (5)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (6)
- Artificial Intelligence (10)
- Big Data (4)
- Bioenergy (2)
- Biology (1)
- Biomedical (4)
- Buildings (1)
- Chemical Sciences (1)
- Composites (3)
- Computer Science (44)
- Coronavirus (2)
- Critical Materials (1)
- Environment (8)
- Exascale Computing (2)
- Fusion (2)
- Grid (1)
- High-Performance Computing (10)
- Machine Learning (1)
- Materials (5)
- Materials Science (9)
- Microscopy (2)
- Molten Salt (3)
- National Security (1)
- Neutron Science (5)
- Nuclear Energy (17)
- Physics (3)
- Polymers (1)
- Quantum Computing (5)
- Quantum Science (8)
- Summit (16)
- Sustainable Energy (6)
- Transportation (3)
Media Contacts
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.